Daniel Martins-de-Souza

Affiliations: 
Max Planck Institute of Psychiatry 
Area:
Proteomics, Psychiatry, Biomarkers, Schizophrenia, Depression, Mass Spectrometry
Google:
"Daniel Martins-de-Souza"
Mean distance: 9429.35
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

de Almeida V, Alexandrino GL, Aquino A, et al. (2020) Changes in the blood plasma lipidome associated with effective or poor response to atypical antipsychotic treatments in schizophrenia patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 101: 109945
Guest PC, Rahmoune H, Martins-de-Souza D. (2020) Proteomic Analysis of Rat Hippocampus for Studies of Cognition and Memory Loss with Aging. Methods in Molecular Biology (Clifton, N.J.). 2138: 407-417
Guest PC, Martins-de-Souza D. (2020) Liquid Chromatography Tandem Mass Spectrometry Analysis of Proteins Associated with Age-Related Disorders in Human Pituitary Tissue. Methods in Molecular Biology (Clifton, N.J.). 2138: 263-276
Nascimento JM, Saia-Cereda VM, Sartore RC, et al. (2019) Human Cerebral Organoids and Fetal Brain Tissue Share Proteomic Similarities. Frontiers in Cell and Developmental Biology. 7: 303
Zuccoli GS, Guest PC, Martins-de-Souza D. (2019) Effects on Glial Cell Glycolysis in Schizophrenia: An Advanced Aging Phenotype? Advances in Experimental Medicine and Biology. 1178: 25-38
Brandão-Teles C, de Almeida V, Cassoli JS, et al. (2019) Corrigendum: Biochemical Pathways Triggered by Antipsychotics in Human Oligodendrocytes: Potential of Discovering New Treatment Targets. Frontiers in Pharmacology. 10: 344
Martins-de-Souza D, Guest PC, Steiner J. (2019) A proteomic signature associated to atypical antipsychotic response in schizophrenia patients: a pilot study. European Archives of Psychiatry and Clinical Neuroscience
Brandão-Teles C, de Almeida V, Cassoli JS, et al. (2019) Oligodendrocytes: Potential of Discovering New Treatment Targets. Frontiers in Pharmacology. 10: 186
Silva-Costa LC, Carlson PT, Guest PC, et al. (2019) Proteomic Markers for Depression. Advances in Experimental Medicine and Biology. 1118: 191-206
Reis-de-Oliveira G, Fioramonte M, Martins-de-Souza D. (2019) A Complete Proteomic Workflow to Study Brain-Related Disorders via Postmortem Tissue. Methods in Molecular Biology (Clifton, N.J.). 1916: 319-328
See more...